In honor of National Pancreatic Cancer Awareness Month (November) and the World Pancreatic Cancer Day (November 18th), we’ve compiled important statistics about this disease and how we plan to treat it. Pancreatic cancer is one of the deadliest forms of cancer. It is the third leading cause of cancer-related deaths in the western world and
Read more →PharmaCyte Biotech, which specializes in cell-based treatments for cancer and diabetes has announced that its clinical trial product, CypCaps™, remains stable and active after 18 months when stored at -80°C. The next timepoint milestone for the product comes at 24 months. CypCaps are genetically engineered human cells, specifically engineered to treat unresectable pancreatic cancer, and
Read more →By BIOTUESDAYS PharmaCyte Biotech (OTCQB:PMCB) is developing cellular therapies for its lead pancreatic cancer program and for diabetes that are based on a proprietary cellulose-based live cell encapsulation technology known as a Cell-in-a-Box. “When used for pancreatic cancer treatment, the combination of Cell-in-a-Box encapsulation plus a cancer prodrug, which needs to be converted to its
Read more →Analysis | By Brian Salmons and Walter H. Gunzburg The therapy is based on induced pluripotent stem cells that are engineered to become insulin-producing beta cells The recently announced licencing deal between Eli Lilly and Sigilon to develop an allogeneic, off-the-shelf, cell therapy to treat type 1 diabetes has finally demonstrated acceptance by the mainstream
Read more →For many, holidays are a time of joy and celebration, but for diabetics, they could also be filled with stress and diabetes-related problems. A 2014 study published in Diabetes Care revealed that in the month after Christmas, diabetics’ HbA1c, average blood glucose level, cholesterol level, and weight increases. Part of this is due to
Read more →INTRODUCTION Regenerative medicine is not all that new; tissue and organ transplants have been around for decades. However, the Mayo Clinic has said, “But advances in developmental and cell biology, immunology, and other fields have unlocked new opportunities to refine existing regenerative therapies and develop novel ones.” It has also stated, “Regenerative medicine is a
Read more →Diabetes News Journal Article By Katie McCallum A collaboration between Prof. Ann Simpson of the University of Technology Sydney (UTS) in Australia and a U.S. clinical stage biotechnology company, PharmaCyte Biotech, shows promise for a unique alternative therapy for a generation of type 1 diabetes patients. Utilizing human liver cells engineered to supply the
Read more →Written by Ι Dr. Ron Korn, Founder, Chairman and Chief Medical Officer at Imaging Endpoints “I keep dreaming of a future, a future with a long and healthy life, not lived in the shadow of cancer but in the light” – Patrick Swayze Introduction Pancreatic cancer is one of the most lethal malignancies. It is often
Read more →PharmaVOICE Magazine September 2015 Edition NOTE: The content below contains the first few paragraphs of the printed article and the titles of the sidebars and boxes, if applicable. The oncology market is changing. Scientific advances are transforming cancer treatments, with outcomes for patients improving. At the same time, patients are challenged by access concerns
Read more →BioWorld Article by Marie Powers News Editor Considering its relatively inconspicuous presence in the body, the pancreas can wreak havoc on human health through two major diseases: diabetes and pancreatic cancer. Both can be deadly – the former from the condition itself or from long-term complications and the latter from advanced disease that may be
Read more →PharmaCyte Biotech Inc.
3960 Howard Hughes Parkway, Suite 500
Las Vegas, Nevada 89169
Office Number: 917.595.2850
Facsimile Number: 917.595.2851
Email: [email protected]
